Peter Gmeiner

Department of Chemistry and Pharmacy, Friedrich-Alexander University Erlangen-Nuernberg

Affiliated withFriedrich-Alexander University Erlangen-Nuernberg

Research Area

Biography

Peter Gmeiner has not added Biography.
If you are Peter Gmeiner and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2020

Other Publications

Article	Year
In vivo monitoring of the antiangiogenic effect of neurotensin receptor-mediated radiotherapy by small-animal positron emission tomography: a pilot study. Pharmaceuticals (Basel, Switzerland)\| PubMed ID: 24743103	2014
Covalent agonists for studying G protein-coupled receptor activation. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 25006259	2014
Synthesis and binding profile of haloperidol-based bivalent ligands targeting dopamine D(2)-like receptors. Bioorganic & medicinal chemistry letters\| PubMed ID: 25047579	2014
Structure-based evolution of subtype-selective neurotensin receptor ligands. ChemistryOpen\| PubMed ID: 25478316	2014
Selective GPCR ligands. Bioorganic & medicinal chemistry\| PubMed ID: 25818769	2015
1,4-Disubstituted aromatic piperazines with high 5-HT2A/D2 selectivity: Quantitative structure-selectivity investigations, docking, synthesis and biological evaluation. Bioorganic & medicinal chemistry\| PubMed ID: 26299826	2015
Arrestin-Bound Rhodopsin: A Molecular Structure and its Impact on the Development of Biased GPCR Ligands. Angewandte Chemie (International ed. in English)\| PubMed ID: 26361376	2015
Structure-guided development of dual β2 adrenergic/dopamine D2 receptor agonists. Bioorganic & medicinal chemistry\| PubMed ID: 27132867	2016
NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids. Bioorganic & medicinal chemistry\| PubMed ID: 27842797	2017
Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors. Pharmaceuticals (Basel, Switzerland)\| PubMed ID: 28287433	2017
Hydroxy-Substituted Heteroarylpiperazines: Novel Scaffolds for β-Arrestin-Biased DR Agonists. Journal of medicinal chemistry\| PubMed ID: 28489379	2017
Development of molecular tools based on the dopamine D receptor ligand FAUC 329 showing inhibiting effects on drug and food maintained behavior. Bioorganic & medicinal chemistry\| PubMed ID: 28495386	2017
Potent haloperidol derivatives covalently binding to the dopamine D2 receptor. Bioorganic & medicinal chemistry\| PubMed ID: 28666858	2017
β-Arrestin biased dopamine D2 receptor partial agonists: Synthesis and pharmacological evaluation. Bioorganic & medicinal chemistry\| PubMed ID: 28870802	2017
Visualization of ligand-induced dopamine D and D receptor internalization by TIRF microscopy. Scientific reports\| PubMed ID: 28883522	2017
Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 30404914	2018
Monitoring of the dopamine D2 receptor agonists hordenine and N-methyltyramine during the brewing process and in commercial beer samples. Food chemistry\| PubMed ID: 30409657	2019
Development of covalent antagonists for β1- and β2-adrenergic receptors. Bioorganic & medicinal chemistry\| PubMed ID: 31151791	2019
Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations. Journal of molecular modeling\| PubMed ID: 31209646	2019
Rational design of agonists for bitter taste receptor TAS2R14: from modeling to bench and back. Cellular and molecular life sciences : CMLS\| PubMed ID: 31236627	2020